SEC Form 4 · accession 0001193125-26-394831
TENAX THERAPEUTICS, INC. · TENX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Declan Doogan
Director
Period of report
Sep 16, 2026
Accepted (ET)
Sep 17, 2026 · 9:30 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000034956
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 16, 2026 | P | 53,000 | $1.92 | A | 55,274 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) | $13.30 | holding | — | — | — | Jan 9, 2027 | Jan 9, 2036 | Common Stock | 30,000 | 30,000 | D |
| Stock Option (right to buy) | $5.75 | holding | — | — | — | Jul 1, 2026 | Jul 1, 2035 | Common Stock | 80,000 | 80,000 | D |
| Stock Option (right to buy) | $5.94 | holding | — | — | — | Dec 10, 2025 | Dec 10, 2034 | Common Stock | 100,000 | 100,000 | D |
| Stock Option (right to buy) | $992.00 | holding | — | — | — | Jun 9, 2023 | Jun 9, 2032 | Common Stock | 4 | 4 | D |
| Stock Option (right to buy) | $3,200.00 | holding | — | — | — | Jun 10, 2022 | Jun 10, 2031 | Common Stock | 4 | 4 | D |